News for Jazz Pharmaceuticals plc (JAZZ)

PR NewswireDUBLIN, April 25, 2025 DUBLIN, April 25, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Committee for Med

PR NewswireDUBLIN, April 23, 2025 Statistically significant and clinically meaningful progression-free survival (PFS) and overall survival (OS) data for Ze

Jazz Pharmaceuticals (NASDAQ:JAZZ) stock drops 6% amid biopharma selloff after a $145M antitrust settlement over Xyrem lawsuits. Read more here.

We advise investors to use the price dip in JAZZ stock as a buying opportunity despite the dynamic shifts in the regulatory landscape.

**media[589577]**

Key Takeaways: The pharmaceutical sector is bracing for potential impacts from new U.S. tariffs. Jazz Pharmaceuticals (JAZZ) could see a significant upsi

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands against the other best mid cap biotech stocks to buy. Is the Biotech Sector Oversaturated? On March 6, Jared Holz, Mizuho health care […]

**media[576922]**

**media[576525]**

On March 24, 2025, EcoR1 Capital, LLC (Trades, Portfolio), a prominent investment firm, made a strategic move by increasing its stake in Zymeworks Inc (ZYME). T

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

MPLX LP, Leidos, Jazz Pharmaceuticals, Fortinet and Pilgrim's Pride have been highlighted in this Screen of The Week article.

After bursting onto the scene several years ago with considerable fanfare, much of the hype about cannabis stocks has quietly died down, and share prices have largely followed suit. Here, we’ll examine three profitable and cheap cannabis-related stocks that offer investors long-term value and potential upside: Turning Point Brands (TPB), Aurora Cannabis (ACB), and Jazz Pharmaceuticals (JAZZ). Cannabis Potential Released From Government Dungeons Having been illegal for decades, cannabis is seeing

On March 19, 2025, EcoR1 Capital, LLC (Trades, Portfolio) executed a notable transaction by acquiring an additional 228,463 shares of Zymeworks Inc at a trade p

On March 13, 2025, EcoR1 Capital, LLC (Trades, Portfolio), a prominent investment firm, made a significant move by acquiring an additional 1,081,980 shares of Z

Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of products spanning ...

PR NewswireNEW YORK, March 17, 2025 NEW YORK, March 17, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations